[go: up one dir, main page]

GB9122305D0 - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number
GB9122305D0
GB9122305D0 GB919122305A GB9122305A GB9122305D0 GB 9122305 D0 GB9122305 D0 GB 9122305D0 GB 919122305 A GB919122305 A GB 919122305A GB 9122305 A GB9122305 A GB 9122305A GB 9122305 D0 GB9122305 D0 GB 9122305D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic agents
therapeutic
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB919122305A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Priority to GB919122305A priority Critical patent/GB9122305D0/en
Publication of GB9122305D0 publication Critical patent/GB9122305D0/en
Priority to GB929220570A priority patent/GB9220570D0/en
Priority to MX9205778A priority patent/MX9205778A/en
Priority to EP92309566A priority patent/EP0539153B1/en
Priority to AT92309566T priority patent/ATE152103T1/en
Priority to PL92296229A priority patent/PL169716B1/en
Priority to JP28187292A priority patent/JP3285963B2/en
Priority to NO924066A priority patent/NO178696C/en
Priority to KR1019920019226A priority patent/KR930007907A/en
Priority to HU9203288A priority patent/HUT65626A/en
Priority to IL92103478A priority patent/IL103478A0/en
Priority to TW081108329A priority patent/TW223061B/en
Priority to CS923175A priority patent/CZ317592A3/en
Priority to DE69223736T priority patent/DE69223736T2/en
Priority to JP28186292A priority patent/JP3157924B2/en
Priority to CA002080950A priority patent/CA2080950A1/en
Priority to RU92004356A priority patent/RU2079492C1/en
Priority to EP92309567A priority patent/EP0539154B1/en
Priority to AT92309567T priority patent/ATE161531T1/en
Priority to US07/963,863 priority patent/US5340819A/en
Priority to MYPI92001895A priority patent/MY106661A/en
Priority to NZ244822A priority patent/NZ244822A/en
Priority to FI924744A priority patent/FI924744A/en
Priority to DE69219271T priority patent/DE69219271T2/en
Priority to CA002080949A priority patent/CA2080949A1/en
Priority to AU27139/92A priority patent/AU659500B2/en
Priority to PL31286792A priority patent/PL170235B1/en
Priority to US07/963,798 priority patent/US5258390A/en
Priority to ZA928102A priority patent/ZA928102B/en
Priority to US08/193,346 priority patent/US5484792A/en
Pending legal-status Critical Current

Links

GB919122305A 1991-10-21 1991-10-21 Therapeutic agents Pending GB9122305D0 (en)

Priority Applications (30)

Application Number Priority Date Filing Date Title
GB919122305A GB9122305D0 (en) 1991-10-21 1991-10-21 Therapeutic agents
GB929220570A GB9220570D0 (en) 1991-10-21 1992-09-30 Therapeutic agent
MX9205778A MX9205778A (en) 1991-10-21 1992-10-08 THERAPEUTIC AGENT.
ZA928102A ZA928102B (en) 1991-10-21 1992-10-20 Therapeutic agent.
JP28186292A JP3157924B2 (en) 1991-10-21 1992-10-20 Therapeutic agent
RU92004356A RU2079492C1 (en) 1991-10-21 1992-10-20 Derivative of 1,8-acridinedione, pharmaceutical composition for bladder relaxing, substance relaxing bladder, methods of synthesis (variants)
PL92296229A PL169716B1 (en) 1991-10-21 1992-10-20 Method of obtaining 9-(3-cyanophenyl)-3, 4, 6, 7, 9, 10-hexahydro-1,8-(2h, 5h) acrydine dione )
JP28187292A JP3285963B2 (en) 1991-10-21 1992-10-20 Therapeutic agent
NO924066A NO178696C (en) 1991-10-21 1992-10-20 Acridine compound and pharmaceutical composition containing it
KR1019920019226A KR930007907A (en) 1991-10-21 1992-10-20 9- (3-cyanophenyl) -3,4,6,7,9,10-hexahydro-1,8- (2H, 5H) acridindione compound
HU9203288A HUT65626A (en) 1991-10-21 1992-10-20 Process for producing of acridinedione derivatives and pharmaceutical compositions comprising them
IL92103478A IL103478A0 (en) 1991-10-21 1992-10-20 Therapeutic agent
TW081108329A TW223061B (en) 1991-10-21 1992-10-20 9-(3-cyanophenyl)-3,4,6,7,9,10-hexahydro-1,8-(2h,5h)-acridinedione and pharmaceutical compositions containing same
CS923175A CZ317592A3 (en) 1991-10-21 1992-10-20 9-(3-cyanophenyl)-3,4,6,7,9,10-hexahydro-1,8-(2h, 5h)-acridinedione, process of its preparation and pharmaceutical composition comprising thereof
DE69223736T DE69223736T2 (en) 1991-10-21 1992-10-20 Acridine-1,8-dione derivatives as therapeutic agents
EP92309566A EP0539153B1 (en) 1991-10-21 1992-10-20 Acridine derivative as therapeutic agent
CA002080950A CA2080950A1 (en) 1991-10-21 1992-10-20 Therapeutic agent
AT92309566T ATE152103T1 (en) 1991-10-21 1992-10-20 ACRIDINE DERIVATIVE AS A THERAPEUTIC AGENT
EP92309567A EP0539154B1 (en) 1991-10-21 1992-10-20 Acridine-1,8-dione-derivatives as therapeutic agents
AT92309567T ATE161531T1 (en) 1991-10-21 1992-10-20 ACRIDINE-1,8-DIONE DERIVATIVES AS A THERAPEUTIC AGENT
US07/963,863 US5340819A (en) 1991-10-21 1992-10-20 Method for treating urinary incontinence using 9-(3-nitrophenyl)-3,4,6,7,9,10-hexahydro-1,8-(2H,5H) acridinedione
MYPI92001895A MY106661A (en) 1991-10-21 1992-10-20 Therapeutic agent
NZ244822A NZ244822A (en) 1991-10-21 1992-10-20 9-(3-cyanophenyl)-3,4,6,7,9,10-hexahydro-1,8-(2h,5h)acridinedione and pharmaceutical compositions
FI924744A FI924744A (en) 1991-10-21 1992-10-20 THERAPEUTIC AEMNEN
DE69219271T DE69219271T2 (en) 1991-10-21 1992-10-20 Acridine derivative as a therapeutic agent
CA002080949A CA2080949A1 (en) 1991-10-21 1992-10-20 Therapeutic agents
AU27139/92A AU659500B2 (en) 1991-10-21 1992-10-20 Therapeutic agent
PL31286792A PL170235B1 (en) 1991-10-21 1992-10-20 Method of obtaining 9-(3-cyanophenyl)-3,4,6,7,9,10-heksahydro-1,8-(2h,5h)acridinodione
US07/963,798 US5258390A (en) 1991-10-21 1992-10-20 9-(3 cyanophenyl) hexahydro-1,8 acridinedione
US08/193,346 US5484792A (en) 1991-10-21 1994-02-08 1,8-(2H,5H)-acridinedione therapeutic agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919122305A GB9122305D0 (en) 1991-10-21 1991-10-21 Therapeutic agents

Publications (1)

Publication Number Publication Date
GB9122305D0 true GB9122305D0 (en) 1991-12-04

Family

ID=10703275

Family Applications (1)

Application Number Title Priority Date Filing Date
GB919122305A Pending GB9122305D0 (en) 1991-10-21 1991-10-21 Therapeutic agents

Country Status (4)

Country Link
GB (1) GB9122305D0 (en)
PL (1) PL170235B1 (en)
RU (1) RU2079492C1 (en)
ZA (1) ZA928102B (en)

Also Published As

Publication number Publication date
PL170235B1 (en) 1996-11-29
ZA928102B (en) 1993-04-21
RU2079492C1 (en) 1997-05-20

Similar Documents

Publication Publication Date Title
GB9121028D0 (en) Therapeutic agents
GB9119704D0 (en) Therapeutic agents
GB9103454D0 (en) Therapeutic agents
GB9117852D0 (en) Therapeutic agents
GB9116113D0 (en) Therapeutic agents
GB9104136D0 (en) Therapeutic agents
GB9111376D0 (en) Therapeutic agents
GB9116241D0 (en) Therapeutic agents
EG19704A (en) Therapeutic agents
GB9113887D0 (en) Therapeutic agents
GB9114551D0 (en) Therapeutic agents
GB9107438D0 (en) Therapeutic agents
GB9107439D0 (en) Therapeutic agents
GB9107625D0 (en) Therapeutic agents
GB9108356D0 (en) Therapeutic agents
GB9109816D0 (en) Therapeutic agents
GB9109974D0 (en) Therapeutic agents
GB9110437D0 (en) Therapeutic agents
GB9110438D0 (en) Therapeutic agents
GB9110924D0 (en) Therapeutic agents
GB9111371D0 (en) Therapeutic agents
GB9106917D0 (en) Therapeutic agents
GB9113415D0 (en) Therapeutic agents
GB9113567D0 (en) Therapeutic agents
GB9105742D0 (en) Therapeutic agents